Alice Zheng, MD

Alice has been a women’s health enthusiast throughout her career spanning global health, clinical medicine, and the private sector. She is currently a Principal at RH Capital, a women’s health-focused early-stage VC fund investing companies across the life sciences, digital health and consumer health. Investment led include AOA (ovarian cancer), Evvy (vaginal microbiome), Millie (maternity care), Cofertility (family building), Seven Starling (women’s mental health) and Eli (hormonal health).

Previously, Alice was a women’s health practice leader and management consultant at McKinsey & Company, where she served biopharma, diagnostics, global public health and private equity clients across R&D and commercial strategy topics.  Earlier in her career, Alice’s passion to improve lives for the underserved led her to work in East Africa and Asia in reproductive health and family planning. As a clinician, she focused on women’s health globally and published articles examining healthcare in low-income countries.

Alice holds an MBA from Harvard Business School and MD and MPH from the University of Michigan, where she was a Dean’s Merit Scholar. Alice has been actively evolved in the women’s health innovation ecosystem since its inception with advising and mentoring roles with health accelerators, convenings and more. She has also been a patient in many women’s health areas including infertility, termination, and pregnancy complications.


Principal, RH Capital


Join our email list to receive exclusive offers

Opt In